In a healthcare system obsessed with hospital consolidation and outpatient surgery centers, Meditrina is making a bold counter-move: bringing advanced intrauterine procedures directly to the physician's office. Their $38.2M funding isn't just capital—it's a vote of confidence in decentralized gynecological care.

"Meditrina isn't just selling medical devices—they're selling back time, autonomy, and margins to gynecologists tired of hospital bureaucracy."

What's telling is their digital footprint: zero monthly website visits, no organic keywords, no backlinks. This isn't a company competing for patient eyeballs. Their sales motion is entirely B2B—direct to physician practices, medical conferences, and hospital networks. The absence of SEO traffic isn't a failure; it's a signal of their enterprise-focused GTM strategy.

• Single-device workflow eliminates the need for separate suction, visualization, and tissue removal systems
• In-office procedures reduce costs by 60-80% compared to hospital-based surgery
• Direct-to-physician sales model bypasses traditional hospital procurement channels
• The 99-employee team suggests heavy reliance on contract manufacturing and outsourced R&D